Zealand Pharma A/S | |
Stock Exchange | Copenhagen Stock Exchange |
EPS |
DKK17.75 |
Market Cap |
DKK4.68 B |
Shares Outstanding |
31.81 M |
Public Float |
24.48 M |
Address |
Smedeland 36 Glostrup ZE 2600 Denmark |
Employees | - |
Website | http://www.zealandpharma.com |
Updated | 07/08/2019 |
Zealand Pharma A/S is a biotechnology company that engages in the discovery, design, and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark. |